Trial NCT02268825

View at ClinicalTrials.gov 
Org. Study IDs: HCI76239

Last trial update was posted on 2018-11-13

MeSH Interventions

Pembrolizumab

MeSH Conditions

Gastrointestinal Neoplasms

Other Conditions

Advanced GI Cancer

Stopping Reasons

Merck requested to change MK-3475 dosing schedule; PI decided to close instead

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID